BPC 157 Ligament: 1 Unsafe Truth The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective MSK Doctor Zaid Matti When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to weigh easing limits on unproven peptides promoted by RFK Jr.